Exhibit 99.1
Joint Filing Agreement
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G dated November 16, 2020 (including amendments thereto) with respect to the Common Stock, $0.0001 par value, of Ocuphire Pharma, Inc.. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
| Dated: November 16, 2020 | Richmond Brothers, Inc. | ||
| By: |
/s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title: | Chairman | ||
| RBI Private Investment III, LLC | |||
| By: | RBI PI Manager, LLC | ||
| Manager | |||
| By: |
/s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title: | Manager | ||
| The RBI Opportunities Fund, LLC | |||
| By: | RBI PI Manager, LLC | ||
| Manager | |||
| By: |
/s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title: | Manager | ||
| The RBI Opportunities Fund II, LLC | |||
| By: | RBI PI Manager, LLC | ||
| Manager | |||
| By: |
/s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title: | Manager | ||
| By: | RBI PI Manager, LLC | ||
| By: |
/s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title: | Manager | ||
|
/s/ David S. Richmond | |
| David S. Richmond |
|
/s/ Matthew J. Curfman | |
| Matthew J. Curfman |